NCT05742438View on ClinicalTrials.gov

Effects of Dexmedetomidine/Lidocaine/Intrathecal Morphine on Cancer Metastasis Biomarker After Colorectal Surgery

NACompletedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

April 12, 2023

Primary Completion Date

July 5, 2023

Study Completion Date

August 5, 2023

Conditions
Colorectal CancerAnesthesiaCancer MetastaticInflammation
Interventions
DRUG

Lidocaine IV

Continuous intravenous infusion of lidocaine

DRUG

Dexmedetomidine IV

Continuous intravenous infusion of dexmedetomidine

DRUG

intrathecal morphine

intrathecal morphine injection

Trial Locations (1)

Unknown

Samsung medical center, Seoul

All Listed Sponsors
collaborator

Korea Institute of Science and Technology

OTHER

lead

Samsung Medical Center

OTHER